首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

市場調查報告書

商品編碼

1753889

2025 年至 2033 年基因分型市場報告（按產品與服務、技術（聚合酶鍊式反應、毛細管電泳、微陣列、定序、質譜等）、應用、最終用戶和地區分類）

Genotyping Market Report by Product and Service, Technology (Polymerase Chain Reaction, Capillary Electrophoresis, Microarray, Sequencing, Mass Spectrometry, and Others), Application, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024 年全球基因分型市場規模達 219 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 633 億美元，2025-2033 年期間的成長率 (CAGR) 為 11.90%。

基因分型是一種分析程序，透過檢查DNA序列來確定生物體（包括人類、植物、動物和微生物）基因型的遺傳組成。基因檢測使科學家能夠透過生物分析檢測基因差異，從而研究各種遺傳變異，例如DNA結構的變化和單核苷酸多態性。利用這些訊息，可以比較個體之間的差異，同時提供與個體遺傳史相關的資料。另一方面，對病毒和細菌等微生物進行基因分型，可以透過精確定位病毒和細菌性疾病的來源來幫助防止病原體的傳播。

基因分型市場趨勢：

全球市場主要受全球醫療機構對基因型診斷檢測需求不斷成長的驅動。這可以歸因於包括癌症和遺傳性疾病在內的慢性疾病的日益普及。此外，資料分析中生物資訊解決方案和藥物基因組學在藥物研發過程中的日益普及也為市場成長提供了動力。專注於基因組藥物開發和精準醫療研究的研發 (R&D) 活動投資的大幅增加也進一步推動了市場的發展。此外，全球範圍內對用於日益成長的基因分型檢測試劑的需求不斷成長，也為市場帶來了積極的前景。其他一些促進市場成長的因素包括：老年人口的成長（老年人更容易患上各種疾病）、基因分型產品的技術不斷進步、大眾對個人化醫療意識的不斷增強以及醫療保健支出的大幅成長。

本報告回答的關鍵問題：

全球基因分型市場迄今表現如何？未來幾年將如何表現？
COVID-19 對全球基因分型市場有何影響？
主要的區域市場有哪些？
根據產品和服務，市場是如何分類的？
基於技術的市場區隔是怎樣的？
根據應用，市場詳細情形如何？
根據最終用戶，市場是如何分類的？
該產業的價值鏈分為哪些階段？
該行業的主要促進因素和挑戰是什麼？
全球基因分型市場的結構是怎麼樣的？主要參與者是誰？
產業競爭程度如何？

市場結構
關鍵參與者
關鍵參與者簡介
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Eurofins Scientific SE
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Laboratory Corporation of America Holdings
- Qiagen NV
- Standard BioTools Inc.
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112025A5815

The global genotyping market size reached USD 21.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 63.3 Billion by 2033, exhibiting a growth rate (CAGR) of 11.90% during 2025-2033.

Genotyping refers to an analytical procedure that examines DNA sequences to determine the genetic constitution in the genotypes of living organisms, including humans, plants, animals, and microorganisms. Genetic tests enable scientists to examine a variety of genetic deviations, such as changes in DNA structure and single nucleotide polymorphisms, by detecting genetic differences through biological assays. By using this information, the differences between individuals can be compared while providing data related to the genetic history of an individual. Genotyping of microorganisms, such as viruses and bacteria, on the other hand, helps prevent the spread of pathogens by pinpointing the source of viral and bacterial diseases.

Genotyping Market Trends:

The global market is majorly driven by the rising demand for genotypic-based diagnostic testing in healthcare facilities across the globe. This can be attributed to the increasing prevalence of chronic diseases, including cancer and genetic disorders. In addition to this, the rising adoption of bioinformatics solutions in data analysis and pharmacogenomics in the drug discovery and development processes is also providing an impetus to the market growth. The market is further driven by the substantial rise in investments in research and development (R&D) activities focusing on genomic drug development and precision medicine research. Apart from this, the escalating demand for reagents for the augmenting volumes of genotyping tests on the global level is creating a positive outlook for the market. Some of the other factors that are contributing to the growth of the market include the rising geriatric population that is susceptible to developing numerous medical conditions, continual technological advancements in genotyping products, the growing awareness regarding personalized medicines among the masses and a considerable expansion of healthcare expenditure.

Key Market Segmentation:

Breakup by Product and Service:

Instruments
Reagents and Kits
Software and Services

Breakup by Technology:

Polymerase Chain Reaction (PCR)
Capillary Electrophoresis
Microarray
Sequencing
Mass Spectrometry
Others

Breakup by Application:

Pharmacogenomics
Diagnostics and Personalized Medicine
Agricultural Biotechnology
Animal Genetics
Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies
Diagnostics and Research Laboratories
Academic Institutes
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Qiagen N.V, Standard BioTools Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global genotyping market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global genotyping market?
What are the key regional markets?
What is the breakup of the market based on the product and service?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global genotyping market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Genotyping Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product and Service

6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Reagents and Kits
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Polymerase Chain Reaction (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Capillary Electrophoresis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Microarray
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Sequencing
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Mass Spectrometry
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Pharmacogenomics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Diagnostics and Personalized Medicine
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Agricultural Biotechnology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Animal Genetics
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End User

9.1 Pharmaceutical and Biopharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Diagnostics and Research Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Academic Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Agilent Technologies Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Bio-Rad Laboratories Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Danaher Corporation
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
- 15.3.4 Eurofins Scientific SE
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 F. Hoffmann-La Roche AG
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
- 15.3.6 Illumina Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Laboratory Corporation of America Holdings
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
- 15.3.8 Qiagen N.V
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Standard BioTools Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
- 15.3.10 Thermo Fisher Scientific Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Genotyping Market: Major Drivers and Challenges
Figure 2: Global: Genotyping Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Genotyping Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Genotyping Market: Breakup by Product and Service (in %), 2024
Figure 5: Global: Genotyping Market: Breakup by Technology (in %), 2024
Figure 6: Global: Genotyping Market: Breakup by Application (in %), 2024
Figure 7: Global: Genotyping Market: Breakup by End User (in %), 2024
Figure 8: Global: Genotyping Market: Breakup by Region (in %), 2024
Figure 9: Global: Genotyping (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Genotyping (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Genotyping (Reagents and Kits) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Genotyping (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Genotyping (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Genotyping (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Genotyping (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Genotyping (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Genotyping (Capillary Electrophoresis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Genotyping (Capillary Electrophoresis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Genotyping (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Genotyping (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Genotyping (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Genotyping (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Genotyping (Mass Spectrometry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Genotyping (Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Genotyping (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Genotyping (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Genotyping (Pharmacogenomics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Genotyping (Pharmacogenomics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Genotyping (Diagnostics and Personalized Medicine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Genotyping (Diagnostics and Personalized Medicine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Genotyping (Animal Genetics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Genotyping (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Genotyping (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Genotyping (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Genotyping (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Genotyping (Diagnostics and Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Genotyping (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Genotyping (Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Genotyping (Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Global: Genotyping (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Global: Genotyping (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: North America: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: North America: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: United States: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: United States: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Canada: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Canada: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Asia-Pacific: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Asia-Pacific: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: China: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: China: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Japan: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Japan: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: India: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: India: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: South Korea: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: South Korea: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Australia: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Australia: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Indonesia: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Indonesia: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Europe: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Europe: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Germany: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Germany: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: France: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: France: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: United Kingdom: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: United Kingdom: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Italy: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Italy: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Spain: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Spain: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Russia: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Russia: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Latin America: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Latin America: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Brazil: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Brazil: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Mexico: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Mexico: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Others: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Others: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Middle East and Africa: Genotyping Market: Sales Value (in Million USD), 2019 & 2024
Figure 92: Middle East and Africa: Genotyping Market: Breakup by Country (in %), 2024
Figure 93: Middle East and Africa: Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Global: Genotyping Industry: SWOT Analysis
Figure 95: Global: Genotyping Industry: Value Chain Analysis
Figure 96: Global: Genotyping Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Genotyping Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Genotyping Market Forecast: Breakup by Product and Service (in Million USD), 2025-2033
Table 3: Global: Genotyping Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Genotyping Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Genotyping Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Genotyping Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Genotyping Market: Competitive Structure
Table 8: Global: Genotyping Market: Key Players

02-2729-4219

+886-2-2729-4219